Johnson & Johnson ordered to pay $4.7bn in talc cancer lawsuit
The jury has initially awarded $550 million in compensation and added $4.1 billion in punitive damages.
Johnson & Johnson, which is currently battling some 9,000 legal cases involving its signature baby powder, said it was "deeply disappointed" and planned to appeal. "Johnson & Johnson remains confident that its products do not contain asbestos and do not cause ovarian cancer and intends to pursue all available appellate remedies," spokeswoman Carol Goodrich said.
Of the 22 women represented in the case, six have died from ovarian cancer. Lead counsel for the plaintiffs, Mark Lanier said in a statement that J&J had covered up evidence of asbestos in its products for more than 40 years.
Medical experts testified during the six-week trial that asbestos (a known carcinogen) is intermingled with mineral talc, which is the primary ingredient in Johnson & Johnson's Baby Powder and Shower to Shower products.
Asbestos fibers and talc particles were found in the ovarian tissues of many of the women, the plaintiffs said.
"We hope this verdict will get the attention of the J&J board and that it will lead them to better inform the medical community and the public about the connection between asbestos, talc, and ovarian cancer," Lanier said.
"The company should pull talc from the market before causing further anguish, harm, and death from a terrible disease," he added.
For more stories on economy & finance visit RT's business section